SCHEDULE 1 THERAPEUTICS
Schedule 1 Therapeutics is a preclinical stage biopharmaceutical company that develops cannabis-based medicines.
SCHEDULE 1 THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Website Url:
http://www.s1therapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Google Apps For Business Typekit Squarespace Squarespace Hosted
Current Advisors List
Official Site Inspections
http://www.s1therapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Schedule 1 Therapeutics"
S1P Therapeutics
Sep 3, 2024 S1P is a largely extracellular lipid that is necessary for correct immune cell positioning. While disrupting S1P receptor signaling with S1P receptor modulating (SRM) …See details»
S1P Therapeutics - PitchBook
S1P Therapeutics General Information Description. Developer of Spns2 inhibitors designed for the treatment of fibrotic and autoimmune diseases. The …See details»
S1P Therapeutics Inc. | LinkedIn
S1P Therapeutics Inc. Biotechnology Research Blacksburg, VA 37 followers S1PTx is focused on the development of Spns2 inhibitors for the treatment of fibrotic and autoimmune diseases.See details»
About – S1P Therapeutics
S1P Therapeutics is a preclinical-stage biotechnology company focused on developing drugs for the treatment of kidney and autoimmune diseases.See details»
S1P Therapeutics Inc. Overview | SignalHire Company Profile
Summary. S1P Therapeutics (S1PTx) is focused on the development of Spns2 inhibitors for the treatment of fibrotic and autoimmune diseases. Organization WebsiteSee details»
Schedule 1 Therapeutics - Overview, News & Similar companies
View Schedule 1 Therapeutics (www.s1therapeutics.com) location in Illinois, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
S1P Therapeutics (HC3CAHM3NQ68)
S1P Therapeutics (UEI HC3CAHM3NQ68, CAGE 86ZD1) based in Blacksburg VA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Schedule 1 Therapeutics | Chicago, IL, USA Startup - gust.com
S1Tx is in preclinical stage developing FDA/EMA-approved, cannabis-based therapies. We have patentable preclinical discoveries and are one of the few US firms doing federally authorized …See details»
S1 Biopharma - Org Chart, Teams, Culture & Jobs - The Org
View S1 Biopharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
News – S1P Therapeutics
May 2, 2023 Read the latest news about S1P Therapeutics Inc’s novel science, pipeline milestones and funding rounds.See details»
S1 Biopharma 2025 Company Profile: Valuation, …
S1 Biopharma General Information Description. Operator of a biopharmaceutical company intended to develop non-hormonal drugs to treat sexual dysfunction in both women and men.See details»
Schedule 1 Therapeutics - 2025 Company Profile - Tracxn
Mar 24, 2025 Schedule 1 Therapeutics is a funded company based in Chicago (United States), founded in 2018.It operates as a Developer of therapies for the treatment of multiple diseases.See details»
Schedule 1 Therapeutics - highergov.com
Sep 30, 2020 Schedule 1 Therapeutics (UEI TV68WM7PHYW3, CAGE 8DJ23) based in Chicago IL federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Exploring the Significance of S1 Biopharma - synthorum.com
To grasp the full potential and implications of s1 biopharma, understanding its mechanisms of action becomes paramount. These mechanisms elucidate how s1 biopharma interacts with …See details»
G1 Therapeutics - Crunchbase Company Profile & Funding
Organization. G1 Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. G1 Therapeutics is a clinical-stage …See details»
Pipeline – S1P Therapeutics
S1P Therapeutics’ pipeline is focused on addressing kidney diseases with significant need. We believe that our therapeutic strategy of reshaping S1P concentration gradients will establish a …See details»
SiteOne Therapeutics Announces a $100 Million Series C Financing …
Dec 18, 2024 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– SiteOne Therapeutics, Inc., a biopharmaceutical company developing selective ion channel modulators for the …See details»
Efficacy and outcome analysis: monotherapy and combination
Oct 31, 2024 Results indicated that both S-1 monotherapy and combination therapy showed promising efficacy and were well tolerated as second-line or later-line treatments for patients …See details»
NIH-funded research team engineers new drug targeting pain …
Mar 5, 2025 Study of CB1 receptor has implications for chronic pain treatment. WHAT: A research team funded by the National Institutes of Health has developed a medication that …See details»
G1 Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of …See details»